https://investor.ironwoodpharma.com/press-releases/press-release-details/2015/AstraZeneca-and-Ironwood-Report-Positive-Top-Line-Data-from-Phase-III-IBS-C-Trial-Designed-to-Support-Linaclotide-Approval-in-China/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- July 8, 2015